Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies
- 1 May 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 146 (5) , 916-918
- https://doi.org/10.1001/archinte.146.5.916
Abstract
Eighty-four patients with allergic bronchopulmonary aspergillosis (ABPA) were evaluated for a total of 294 patient-years with a mean observation period of 3.7 years and classified by the stage of ABPA. The largest percentage of patients were in the stage IV (corticosteroid-dependent asthma stage) group. The next largest percentage were in the stage V (fibrotic, end-stage lung disease) group. Of the latter 24 patients, either had died. In addition, we described 13 patients with all serologic characteristics of ABPA but without central bronchiectasis. We propose that these patients have seropositive ABPA and represent the earliest cases of it that can be diagnosed in contrast with ABPA with central bronchiectasis in which lung damage is already present.This publication has 5 references indexed in Scilit:
- IGE AND IGG ANTIBODY AGAINST HUMAN (RECOMBINANT DNA) INSULIN IN PATIENTS WITH SYSTEMIC INSULIN ALLERGY1985
- A Radioimmunoassay Index for Allergic Bronchopulmonary AspergillosisAnnals of Internal Medicine, 1983
- Allergic Bronchopulmonary Aspergillosis: Staging as an Aid to ManagementAnnals of Internal Medicine, 1982
- APPLICATION OF ENZYME-LINKED IMMUNOSORBENT-ASSAY (ELISA) IN DIAGNOSIS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS1982
- Clinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary AspergillosisAnnals of Internal Medicine, 1977